Stay updated on Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen with a 403 header and basic navigation. This replaces the previous study-content that was visible on the page.
    Difference
    18%
    Check dated 2026-09-21T20:28:27.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page’s software revision label has been updated from v3.6.5 to v3.6.6, indicating a backend update. This reflects maintenance or bug-fix work rather than changes to visible content or functionality.
    Difference
    0.1%
    Check dated 2026-08-31T18:51:21.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a refreshed version of the ClinicalTrials.gov page. This appears to be a metadata-level update reflecting a new release of the page rather than changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-08-10T12:57:35.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Updated the revision tag from v3.6.3 to v3.6.4 in the page footer, indicating a software version update for the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-27T06:25:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.